StonvexLoading…
StonvexStonvexStonvexCore line items from FNB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.33B | $2.25B | $1.97B | $1.28B |
Operating Income | $669.00M | $555.00M | $584.00M | $553.00M |
Net Income | $565.00M | $465.00M | $485.00M | $439.00M |
EPS (Diluted) | $1.56 | $1.27 | $1.31 | $1.22 |
Total Assets | $50.23B | $48.63B | $46.16B | $43.73B |
Total Liabilities | $43.47B | $42.32B | $40.11B | $38.07B |
Cash & Equivalents | $2.50B | $2.42B | $1.58B | $1.67B |
Free Cash Flow OCF − CapEx | $376.00M | $503.00M | $335.00M | $1.12B |
Shares Outstanding | 361.95M | 362.64M | 362.90M | 354.05M |